SBC Medical Group Holdings (SBC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 May, 2026Executive summary
Annual meeting scheduled for July 9, 2026 (JST) / July 8, 2026 (ET), with virtual participation available.
Shareholders are encouraged to review proxy materials and vote by July 7, 2026.
Voting matters and shareholder proposals
Election of four directors: Yoshiyuki Aikawa, Yuya Yoshida, Ken Edahiro, and Fumitoshi Fujiwara.
Ratification of MaloneBailey, LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal to amend the certificate of incorporation to eliminate plurality voting for directors.
Proposal to allow director removal without cause.
Proposal to opt out of Section 203 of Delaware General Corporation Law.
Proposal to provide for officer exculpation.
Proposal for other technical amendments to the certificate of incorporation.
Board of directors and corporate governance
Board recommends approval of all director nominees and proposed amendments.
Proposed governance changes aim to modernize director election and removal processes.
Latest events from SBC Medical Group Holdings
- Underlying growth, AI-driven efficiency, and longevity-focused expansion drive future prospects.SBC
Sidoti Small-Cap Virtual Investor Conference18 Jun 2026 - AI-driven, multi-brand healthcare model targets global expansion and double-digit growth.SBC
Emerging Growth Conference 9311 Jun 2026 - Largest aesthetic clinic network in Japan, expanding globally with high growth and profitability.SBC
Investor presentation11 Jun 2026 - Scalable clinic network drives growth with data-driven efficiency and a focus on longevity.SBC
Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference3 Jun 2026 - Shareholders will vote on director elections, auditor ratification, and major charter amendments.SBC
Proxy filing28 May 2026 - Shareholders will vote on director elections, auditor ratification, and major charter amendments.SBC
Proxy filing15 May 2026 - Q1 2026 revenue and net income declined, but underlying growth and liquidity remained strong.SBC
Q1 202614 May 2026 - Net income and EPS rose in 2025 despite revenue declines, with growth expected in 2026.SBC
Q4 20257 Apr 2026 - Scalable multi-brand medical group achieves rapid global growth and high customer retention.SBC
Corporate presentation27 Mar 2026